Skip to content

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00772733
Acronym
KOSMOS
Enrollment
936
Registered
2008-10-15
Start date
2008-10-31
Completion date
2010-12-31
Last updated
2011-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Diseases, COPD

Keywords

Quality assurance, rehabilitation, chronic care model, COPD

Brief summary

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD diagnose, verified by spirometry * Having given informed consent

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Control visits at General practitioners6-12 months
Lung function measured by spirometry6-12 months

Secondary

MeasureTime frame
Dyspnoea on MRC scale6-12 months
Smoking status6-12 months
Rehabilitation completed in the municipality rehabilitation team6-12 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026